Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823407 · ClinicalTrials.gov registry record · NA
Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]
A NA study, sponsored by California Pacific Medical Center Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00823407 is a NA study that has completed, run by California Pacific Medical Center Research Institute. The registered enrollment target is 12 participants.
The verdict
NCT00823407, a NA study, has completed, sponsored by California Pacific Medical Center Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.
Interventions
- DRUG Placebo
- DRUG MDA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00823407
The ClinicalTrials.gov registry entry for NCT00823407 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is California Pacific Medical Center Research Institute, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00823407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00823407 about?
NCT00823407 is a clinical study titled "Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine]". The purpose of this study is to investigate the pharmacological and cognitive effects of MDA in healthy humans.
What is the current status of trial NCT00823407?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2009-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00823407?
The interventions under investigation include: Placebo (DRUG), MDA (DRUG).
Who is sponsoring clinical trial NCT00823407?
This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.